Home | Site Map | Contact Us
NYRx, the Medicaid Pharmacy Program
Brand Less Than Generic Program
The Brand Less than Generic Program is a cost containment initiative which promotes the use of certain multi-source brand name drugs when the cost of the brand name drug is less expensive than the generic equivalent. Generic drugs included in this program require prior authorization. Once it is determined that the generic drug is more cost-effective than the brand name equivalent, the prior authorization requirement will be removed for the generic drug. Please keep in mind that multi-source brand name drugs may be included in the Mandatory Generic Drug Program; again promoting the use of the most cost-effective product.
Brand Less than Generic Program Updates